The insolvent German battery cell manufacturer CustomCells has secured a partial rescue with a new investor consortium, enabling a strategic repositioning focused on electric mobility. As reported by Handelsblatt, a takeover agreement was signed on Wednesday evening. There has been no official communication from CustomCells at the time of writing.
According to financial and negotiation sources, the winning consortium is led by existing investor Abacon, joined by two further capital providers.
“CustomCells is a highly innovative German battery pioneer with enormous potential,” commented Abacon CIO Sven Rossmann on behalf of the consortium.
According to the German newspaper, one of the additional investors is Salvia, the family office of…